Epigenetic Longevity Index (ELI)
The Future of Personalized Health and Longevity
At Genknowme, we believe that a long and vibrant life is primarily shaped by how your DNA responds to your lifestyle rather than the genetic blueprint itself. It is not your genes that matter, but how well they cope in your environment. To advance this vision, we are developing the Epigenetic Longevity Index (ELI) – a groundbreaking tool designed to measure biological age, allostatic load, and essential epigenetic markers. ELI aims to empower you to better understand, anticipate, and optimize your health and longevity over time.
What is the Epigenetic Longevity Index?
The Epigenetic Longevity Index (ELI) is a scientific framework under development, created to evaluate epigenetic changes in your DNA and provide a new metric encompassing your biological age – a measure that reveals how well you are ageing – and your allostatic load – the wear and tear that your body has experienced.
Unlike chronological age, biological age reflects the true state of your health and how efficiently your body is aging. Allostatic load is our new proprietary algorithm estimating how your body responds to stressful conditions, real or perceived, by modifying the expression of genes involved in maintaining good health. By analyzing specific epigenetic modifications – biological markers of genetic activity influenced by factors like diet, physical activity, stress, sleep quality and the early response to chronic disease – ELI provides actionable insights into your overall well-being.
Why is it important?
The ELI will serve as a vital indicator to:
- Predict longevity: Understand whether you’re aging faster or slower than expected.
- Identify weak points: Determine which body systems – cardiovascular, immune, metabolic, or neuroendocrine – should be taken care of in priority.
- Improve lifestyle habits: Identify the behaviors that can slow aging and enhance vitality.
- Reduce chronic disease risks: Gain insights into preventing conditions such as cardiovascular disease, diabetes, cancer, or Alzheimer’s.
By establishing the Epigenetic Longevity Index, we are paving the way for a personalized approach to extending your healthy lifespan.
How will ELI work?
Our envisioned process is straightforward and rooted in cutting-edge science:
- Epigenetic Analysis: Using a simple DNA sample, epigenetic markers will be analyzed with advanced sequencing technologies.
- Calculation of Your ELI: Results will be compared to scientific databases to estimate your biological age and derive your personalized index.
- Personalized Report: Your healthcare professional will receive a detailed report with tailored recommendations and guidance to help you act on the findings.
The Benefits of ELI with Genknowme
- Scientific Expertise: Based on the latest breakthroughs in epigenetics and longevity research.
- Personalized Insights: Recommendations precisely aligned with your unique lifestyle and needs.
- Proactive Health Management: Take charge of your well-being before issues arise.
The Future of Personalized Health
While still in development, the Epigenetic Longevity Index represents more than just a metric—it is a transformative tool designed to help you redefine your approach to health and aging. By understanding your biological age and the factors that influence it, you will gain the ability to shape a healthier, more energetic future.
Stay Ahead of the Curve
Interested in learning more about the upcoming Epigenetic Longevity Index? Contact us today to stay informed and join us on the journey toward a longer, healthier, and more fulfilling life.
Live better. Live longer.
Legal Notice
The Epigenetic Longevity Index (ELI) is a proprietary innovation of Genknowme, currently under active development. This initiative reflects our ongoing commitment to pioneering advancements in the field of epigenetics and longevity. All rights and claims associated with the ELI name and concept are reserved under applicable Swiss law.